Silver Spring (MD): U.S
Usually resolves within 4 to 6 weeks Constipation: Related to slowed gastric emptying
Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Hypersensitivity to semaglutide or any excipient Not recommended in pregnancy or breastfeeding Side Effects: Very common : Nausea, vomiting, diarrhea, constipation Common : Abdominal pain, headache, fatigue, decreased appetite Rare : Pancreatitis, gallbladder issues Serious risks : Thyroid C-cell tumors (in animal studies), renal events in context of dehydration WEGOVY contains semaglutide , a GLP-1 receptor agonist that is long-acting and structurally modified for stability and sustained action
Is combining them synergistic
it improves cognitive functions, not only in older adults: Mild stimulation of the central nervous system through caffeine improves attention, concentration, and working memory
The appetite suppression that tirzepatide provided will fade as the compound clears your system
